Cesarean scar pregnancy combined with arteriovenous malformation successfully treated with transvaginal fertility-sparing surgery: A case report and literature review

Medicine (Baltimore). 2020 Jul 31;99(31):e21432. doi: 10.1097/MD.0000000000021432.

Abstract

Introduction: A cesarean scar pregnancy (CSP), when combined with an arteriovenous malformation (AVM), is a rare, but potentially life-threatening condition that may be associated with uncontrolled hemorrhage. Hysterectomy is indicated when conservative treatment fails. Preservation of fertility is challenging.

Patient concerns: We reported a 33-year-old woman with a CSP combined with an AVM who failed methotrexate administration as conservative treatment.

Diagnoses: A CSP combined with an AVM was diagnosed via three-dimensional color Doppler angiogram and magnetic resonance imaging.

Interventions: Transvaginal removal of the ectopic gestation and repair of the uterine defect was performed without incident.

Outcomes: The fertility of the patient was preserved and hysterectomy was avoided.

Conclusion: Transvaginal fertility-sparing surgery may be successfully performed to prevent hysterectomy when conservative treatment fails in patients with a CSP combined with an AVM.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Angiography / methods
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / therapeutic use
  • Arteriovenous Malformations / complications*
  • Arteriovenous Malformations / diagnostic imaging
  • Arteriovenous Malformations / drug therapy
  • Arteriovenous Malformations / surgery*
  • Cesarean Section / adverse effects
  • Cicatrix / pathology*
  • Cicatrix / surgery
  • Female
  • Fertility Preservation / methods*
  • Humans
  • Imaging, Three-Dimensional / methods
  • Magnetic Resonance Imaging / methods
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use
  • Pregnancy
  • Pregnancy, Ectopic / surgery
  • Treatment Outcome
  • Ultrasonography, Doppler, Color / methods

Substances

  • Antimetabolites, Antineoplastic
  • Methotrexate